Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.5133
H.R.5133: Affordable Prescriptions for Patients Through Promoting Competition Act of 2019
About This Bill
- Introduced Nov. 18, 2019
- Latest Major Action Dec. 24, 2020
Bill Sponsor
Bill Cosponsors
5 (2 Democrats, 3 Republicans)
Bill Versions
Bill Summary
Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 This bill prohibits, subject to certain exceptions, the practice of product hopping, which is presumed when a drug manufacturer obtains removal of a drug from the Food and Drug Administration's approved drug list, discontinues a drug, or markets a reformulation of an already approved drug during a certain period after which the manufacturer has been notified that...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
| Date | Description |
|---|---|
| Dec. 24, 2020 |
Placed on the Union Calendar, Calendar No. 578.
|
| Dec. 24, 2020 |
Reported by the Committee on Judiciary. H. Rept. 116-695.
|
| Nov. 21, 2019 |
Ordered to be Reported.
|
| Nov. 21, 2019 |
Committee Consideration and Mark-up Session Held.
|
| Nov. 19, 2019 |
Subcommittee on Antitrust, Commercial, and Administrative Law Discharged.
|
| Nov. 18, 2019 |
Referred to the House Committee on the Judiciary.
|
| Nov. 18, 2019 |
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
|
| Nov. 18, 2019 |
Introduced in the House by David Cicilline (D-R.I.) |